WuXi AppTec Co., Ltd. (WUXAY)

OTCMKTS · Delayed Price · Currency is USD
13.59
-0.33 (-2.37%)
At close: Mar 10, 2026
Market Cap40.81B +80.9%
Revenue (ttm)6.16B +23.2%
Net Income2.11B +85.9%
EPS0.65 +53.2%
Shares Outn/a
PE Ratio19.38
Forward PE17.60
Dividend0.18 (1.28%)
Ex-Dividend DateSep 9, 2025
Volume752
Average Volume1,704
Open14.09
Previous Close13.92
Day's Range13.59 - 14.09
52-Week Range5.73 - 16.35
Beta0.62
RSI41.79
Earnings DateMar 23, 2026

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecula... [Read more]

Sector Healthcare
Founded 2000
Employees 37,832
Stock Exchange OTCMKTS
Ticker Symbol WUXAY
Full Company Profile

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial numbers in CNY Financial Statements